膵臓β細胞内インスリン顆粒動態シミュレーション・モデル;膵臓β細胞内インスリン顆粒動態シミュレーション・モデル;Simulation Model of Insulin Granule Dynamics in Pancreatic Beta Cell

[1]  J. Holst,et al.  Exenatide augments first- and second-phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes. , 2005, The Journal of clinical endocrinology and metabolism.

[2]  K. Docherty,et al.  Glucagon-like peptide-1 stimulates human insulin promoter activity in part through cAMP-responsive elements that lie upstream and downstream of the transcription start site. , 2005, The Journal of endocrinology.

[3]  D. Porte,et al.  Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. , 1976, The Journal of clinical endocrinology and metabolism.

[4]  Zhanxiang Wang,et al.  Mechanisms of biphasic insulin-granule exocytosis – roles of the cytoskeleton, small GTPases and SNARE proteins , 2009, Journal of Cell Science.

[5]  Lena Eliasson,et al.  Fast insulin secretion reflects exocytosis of docked granules in mouse pancreatic B-cells , 2002, Pflügers Archiv.

[6]  T. Shibasaki,et al.  PKA-dependent and PKA-independent pathways for cAMP-regulated exocytosis. , 2005, Physiological reviews.

[7]  G. Rutter,et al.  Kinesin I and cytoplasmic dynein orchestrate glucose-stimulated insulin-containing vesicle movements in clonal MIN6 beta-cells. , 2003, Biochemical and biophysical research communications.

[8]  M. Hussain,et al.  Glucagon-like peptide 1 stimulates insulin gene promoter activity by protein kinase A-independent activation of the rat insulin I gene cAMP response element. , 2000, Diabetes.

[9]  J. Holst,et al.  Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes: a parallel-group study , 2002, The Lancet.

[10]  P. Rorsman,et al.  Insulin granule dynamics in pancreatic beta cells , 2003, Diabetologia.

[11]  J. Miyazaki,et al.  Essential role of Epac2/Rap1 signaling in regulation of insulin granule dynamics by cAMP , 2007, Proceedings of the National Academy of Sciences.

[12]  J. Halter,et al.  Insulin secretion in diabetes mellitus. , 1981, The American journal of medicine.

[13]  T. Vilsbøll,et al.  Liraglutide, a once‐daily human GLP‐1 analogue, improves pancreatic B‐cell function and arginine‐stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitus , 2008, Diabetic medicine : a journal of the British Diabetic Association.